Juzendaihoto administration for esophageal cancer patients

Phase 1

• Conditions: Esophageal cancer

• Registration Number: JPRN-UMIN000036616
• Lead Sponsor: agasaki University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-26
• Last Update Posted: 17 October 2023
• Study Completion: 2023-12-31

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Not provided

Exclusion Criteria

1 Cases in which preoperative chemotherapy or surgery could not be performed 2 Patients with drug hypersensitivity and allergies 3 Pregnant women and patients who may be pregnant or nursing 4 Other patients who the research director judged inappropriate as the research subject

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of postoperative complications Postoperative complications: respiratory complications, suture failure, recurrent nerve paralysis

Secondary Outcome Measures

Name	Time	Method
Assessment of immune and nutritional status by blood and biochemical tests (Lymphocyte count, neutrophil count, monocyte count, platelet count, serum albumin level, CRP) (before chemotherapy, before surgery, 2 months after surgery)